This content is PDF only. Please click on the PDF icon to access.
Despite the decided risk of becoming rapidly obsolete, a critical survey of the large volume of data and reports on the chemotherapy of malignant tumors should be welcomed by most experimental and clinical workers who have to deal with this important problem. Professor Meyerthal has undertaken such a survey as the editor of the first tome of a projected series of three volumes on the "Therapy of Malignant Tumors," published by the firm of Ferdinand Enke in Stuttgart. Already the subtitle of this first volume—"Pathology and Chemotherapy"—struck me as a misnomer, since the pathology is so perfunctorily dealt with that
Therapie maligner Tumoren, Hämoblastome und Hämoglastosen. Band 1. Pathologie und Chemotherapie.. Ann Intern Med. 1966;65:391–392. doi: https://doi.org/10.7326/0003-4819-65-2-391
Download citation file:
Published: Ann Intern Med. 1966;65(2):391-392.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use